Stockreport

Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results  

Inventiva S.A. - American Depository Shares  (IVA) 
PDF Daix (France), New York (United States), March 23, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical c [Read more]